IFNL4 Genotype Does Not Associate with CD4 T-Cell Recovery in People Living with Human Immunodeficiency Virus
- 1 March 2021
- journal article
- research article
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 37 (3), 184-188
- https://doi.org/10.1089/aid.2020.0104
Abstract
Immune non-responders are persons with HIV infection who fail to restore their CD4 T-cell counts in spite of prolonged virologic suppression, a condition associated with higher rates of all-cause mortality. The mechanisms of immune non-response are not entirely clear. We used existing clinical and genetic data from ACTG clinical trials to ask whether an IFNL4 single nucleotide polymorphism, shown to associate with outcomes for other infectious diseases, correlated with immune non-response for HIV. Analysis of data from 426 participants with clearly defined CD4 T-cell recovery phenotypes, including 88 immune non-responders with CD4 <200 cells/mm3 after 2 years of suppressive antiretroviral therapy, did not identify an association of IFNL4 genotype with immune non-response. Thus, IFNL4 genotype is unlikely to influence immunologic recovery.Keywords
This publication has 45 references indexed in Scilit:
- Incomplete Immune Recovery in HIV Infection: Mechanisms, Relevance for Clinical Care, and Possible SolutionsClinical and Developmental Immunology, 2012
- Interferon-Alpha Administration Enhances CD8+ T Cell Activation in HIV InfectionPLOS ONE, 2012
- Skewed T-cell maturation and function in HIV-infected patients failing CD4+ recovery upon long-term virologically suppressive HAARTAIDS, 2010
- Genetic variation in IL28B and spontaneous clearance of hepatitis C virusNature, 2009
- Incomplete Peripheral CD4+Cell Count Restoration in HIV‐Infected Patients Receiving Long‐Term Antiretroviral TreatmentClinical Infectious Diseases, 2009
- The Absence of CD4+T Cell Count Recovery Despite Receipt of Virologically Suppressive Highly Active Antiretroviral Therapy: Clinical Risk, Immunological Gaps, and Therapeutic OptionsClinical Infectious Diseases, 2009
- The Absence of CD4+ T Cell Count Recovery Despite Receipt of Virologically Suppressive Highly Active Antiretroviral Therapy: Clinical Risk, Immunological Gaps, and Therapeutic OptionsClinical Infectious Diseases, 2009
- Poor Initial CD4+ Recovery With Antiretroviral Therapy Prolongs Immune Depletion and Increases Risk for AIDS and Non-AIDS DiseasesJAIDS Journal of Acquired Immune Deficiency Syndromes, 2008
- CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infectionAIDS, 2008
- Stimulated plasmacytoid dendritic cells impair human T-cell developmentBlood, 2006